BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22493401)

  • 1. Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma.
    Lee YY; Choi CH; Kim HJ; Kim TJ; Lee JW; Lee JH; Bae DS; Kim BG
    Anticancer Res; 2012 Apr; 32(4):1555-61. PubMed ID: 22493401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of neutrophil-to-lymphocyte ratio in cervical cancer: A systematic review and meta-analysis of observational studies.
    Huang QT; Man QQ; Hu J; Yang YL; Zhang YM; Wang W; Zhong M; Yu YH
    Oncotarget; 2017 Mar; 8(10):16755-16764. PubMed ID: 28187430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer: a meta-analysis and systematic review.
    Wu J; Chen M; Liang C; Su W
    Oncotarget; 2017 Feb; 8(8):13400-13412. PubMed ID: 28077792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer.
    Mizunuma M; Yokoyama Y; Futagami M; Aoki M; Takai Y; Mizunuma H
    Int J Clin Oncol; 2015 Oct; 20(5):989-96. PubMed ID: 25736530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of systemic hemato-immunological indices in uterine cervical cancer: A systemic review, meta-analysis, and meta-regression of observational studies.
    Han X; Liu S; Yang G; Hosseinifard H; Imani S; Yang L; Maghsoudloo M; Fu S; Wen Q; Liu Q
    Gynecol Oncol; 2021 Jan; 160(1):351-360. PubMed ID: 33092868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomograms for predicting prognostic value of combined neutrophil-to-lymphocyte ratio and SCC-Ag in locally advanced cervical cancer.
    Jin L; Cao F; Zhang Y; Dang Y; Wang F
    Transl Cancer Res; 2024 Mar; 13(3):1323-1335. PubMed ID: 38617514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoding the Complexity of Systemic Inflammation Predictors in Locally Advanced Cervical Cancer, with Hemoglobin as the Hidden Key (the ESTHER Study).
    Medici F; Ferioli M; Forlani L; Laghi V; Ma J; Cilla S; Buwenge M; Macchia G; Deodato F; Vadalà M; Malizia C; Tagliaferri L; Perrone AM; De Iaco P; Strigari L; Arcelli A; Morganti AG
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Classical Prognostic Factors Predict Prognosis Better than Inflammatory Indices in Locally Advanced Cervical Cancer: Results of a Comprehensive Observational Study including Tumor-, Patient-, and Treatment-Related Data (ESTHER Study).
    Ferioli M; Benini A; Malizia C; Forlani L; Medici F; Laghi V; Ma J; Galuppi A; Cilla S; Buwenge M; Macchia G; Zamagni C; Tagliaferri L; Perrone AM; De Iaco P; Strigari L; Morganti AG; Arcelli A
    J Pers Med; 2023 Aug; 13(8):. PubMed ID: 37623479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer.
    Son J; Lin HY; Fu S; Biter AB; Dumbrava EE; Karp DD; Naing A; Pant S; Piha-Paul SA; Rodon J; Subbiah V; Tsimberidou AM; Yap TA; Frumovitz MM; Jazaeri AA; Ramirez PT; Westin SN; Yuan Y; Meric-Bernstam F; Hong DS
    J Immunother Precis Oncol; 2023 Feb; 6(1):10-18. PubMed ID: 36751659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Utility of Pre-Treatment Inflammation Markers as Associative Factors to the Adverse Outcomes of Vulvar Cancer: A Study on Staging, Nodal Involvement, and Metastasis Models.
    Winarto H; Habiburrahman M; Anggraeni TD; Nuryanto KH; Julianti RA; Purwoto G; Andrijono A
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36614896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance.
    Chakravarthy A; Reddin I; Henderson S; Dong C; Kirkwood N; Jeyakumar M; Rodriguez DR; Martinez NG; McDermott J; Su X; Egawa N; Fjeldbo CS; Skingen VE; Lyng H; Halle MK; Krakstad C; Soleiman A; Sprung S; Lechner M; Ellis PJI; Wass M; Michaelis M; Fiegl H; Salvesen H; Thomas GJ; Doorbar J; Chester K; Feber A; Fenton TR
    Nat Commun; 2022 Oct; 13(1):5818. PubMed ID: 36207323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report.
    Madeddu C; Sanna E; Nemolato S; Mulas O; Oppi S; Scartozzi M; La Nasa G; Maccio A
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of neutrophil-to-lymphocyte-ratio in neoadjuvant-treated patients with breast cancer.
    von Au A; Shencoru S; Uhlmann L; Mayer L; Michel L; Wallwiener M; Hennigs A; Deutsch T; Riedel F; Heil J; Golatta M; Schneeweiss A; Schütz F; Domschke C
    Arch Gynecol Obstet; 2023 Apr; 307(4):1105-1113. PubMed ID: 35980458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors of dose-response relationship for nodal control in metastatic lymph nodes of cervical cancer patients undergoing definitive radiotherapy with concurrent chemotherapy.
    Lee WH; Kim GE; Kim YB
    J Gynecol Oncol; 2022 Sep; 33(5):e59. PubMed ID: 35882603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-Treatment and Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Prognostic Value of Glioblastoma: A Meta-Analysis.
    Guo X; Jiao H; Zhang T; Zhang Y
    Brain Sci; 2022 May; 12(5):. PubMed ID: 35625061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between Neutrophil-to-Lymphocyte Ratio and Pretreatment Magnetic Resonance Imaging and Their Predictive Significance in Cervical Carcinoma Patients Referred for Radiotherapy.
    Liang C; Xu Z; Shen X; Wu K
    J Oncol; 2022; 2022():3409487. PubMed ID: 35342402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of Clinicopathological Factors Influencing Overall Survival and Event-Free Survival of Patients with Cervical Cancer: A Systematic Review and Meta-Analysis.
    Kang S; Wu J; Li J; Hou Q; Tang B
    Med Sci Monit; 2022 Mar; 28():e934588. PubMed ID: 35260545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations of AKIP1, CXCL1 and CXCL2 expressions with clinicopathological features and survival profiles in cervical cancer patients.
    Wan X; Hong Z; Mao Y; Di W
    Transl Cancer Res; 2020 Feb; 9(2):726-734. PubMed ID: 35117418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of preoperative serum inflammation markers in patients with male breast cancer.
    Li X; Wang J; Fu J; Xie X; Xie X
    Transl Cancer Res; 2021 Sep; 10(9):4002-4008. PubMed ID: 35116698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between unintentional splenic radiation and lymphopenia and high neutrophil/lymphocyte ratio after radiotherapy in patients with esophageal cancer.
    Sakaguchi M; Maebayashi T; Aizawa T; Ishibashi N; Okada M
    Transl Cancer Res; 2021 Dec; 10(12):5076-5084. PubMed ID: 35116359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.